Picture of medmix AG logo

MEDX medmix AG Share Price

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Momentum

Relative Strength (%)
1m+3.29%
3m-11.54%
6m-24.88%
1yr-19.03%
Volume Change (%)
10d/3m-26.68%
Price vs... (%)
52w High-38.84%
50d MA+4.92%
200d MA-14.17%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)17.06
PEG Ratio (f)0.34
EPS Growth (f)100.71%
Dividend Yield (f)4.39%
Valuation (ttm)IndustryMarket
Price to Book Value1.43
Price to Tang. Book9.64
Price to Free Cashflow208.5
Price to Sales1.37
EV to EBITDA12.68

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital1.93%
Return on Equity0.06%
Operating Margin3.29%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueCH₣m420.7351.3457.3477.1486.6518.57557.21.4%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-34.49-65.72+191.51-19.42-72.69+254.18+32.67n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of medmix AG EPS forecast chart

Profile Summary

Medmix Systems AG is a Switzerland-based company active in manufacturing of high-precision delivery devices. The Company operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    September 20th, 2021
    Public Since
    September 30th, 2021
    No. of Shareholders
    7,967
    No. of Employees
    2,658
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    ch flag iconSIX Swiss Exchange
    Shares in Issue
    40,781,847
    Blurred out image of a map
    Address
    Neuhofstrasse 20, BAAR, 6340
    Web
    Phone
    +41 417237300
    Auditors
    KPMG AG

    MEDX Share Price Performance

    Similar to MEDX

    Picture of Alcon AG logo

    Alcon AG

    ch flag iconSIX Swiss Exchange

    Picture of COLTENE Holding AG logo

    COLTENE Holding AG

    ch flag iconSIX Swiss Exchange

    Picture of IVF Hartmann Holding AG logo

    IVF Hartmann Holding AG

    ch flag iconSIX Swiss Exchange

    Picture of Medacta SA logo

    Medacta SA

    ch flag iconSIX Swiss Exchange

    Picture of Medartis Holding AG logo

    Medartis Holding AG

    ch flag iconSIX Swiss Exchange

    FAQ